AI Insight
The CellCelector CLD is a technology platform designed to accelerate the identification and selection of high-producing clonal cell lines from large pools of candidate clones. By integrating automated imaging, single-cell dispensing, and early productivity screening, the system aims to reduce the time and resources required during the cell line development stage of biopharmaceutical manufacturing. The platform enables researchers to narrow down thousands of initial candidates to a smaller set of top-performing clones with greater efficiency than conventional workflows.
Why it matters
Faster and more resource-efficient clone selection has direct implications for reducing the cost and timeline of biologics development, including the production of therapeutic antibodies and recombinant proteins, which are central to modern medicine.
Rapid preselection of high-producing clones from candidate pools, saving resources